Cargando…

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”

Detalles Bibliográficos
Autores principales:	Dos Santos-Júnior, Amilton, Henriques, Taciane Barbosa, de Mello, Maricilda Palandi, Della Torre, Osmar Henrique, Paes, Lúcia Arisaka, Ferreira-Neto, Adriana Perez, Sewaybricker, Letícia Esposito, Fontana, Thiago Salum, Celeri, Eloisa Helena Rubello Valler, Guerra-Júnior, Gil, Dalgalarrondo, Paulo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448052/ https://www.ncbi.nlm.nih.gov/pubmed/28592969 http://dx.doi.org/10.1155/2017/8165368

Ejemplares similares

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
por: Dos Santos-Júnior, Amilton, et al.
Publicado: (2016)

Dopamine D2 receptor gene polymorphisms and externalizing behaviors in children and adolescents
por: Della Torre, Osmar Henrique, et al.
Publicado: (2018)

Quality of life, depression and anxiety in children and adolescents with CKD and their primary caregivers
por: Elorza, Cibele Longobardi Cutinhola, et al.
Publicado: (2023)

Resilience and mental health problems in children and adolescents who have been victims of violence
por: Hildebrand, Natália Amaral, et al.
Publicado: (2019)

Association between serotonin 2C receptor gene (HTR2C) polymorphisms and psychopathological symptoms in children and adolescents
por: Paes, L.A., et al.
Publicado: (2018)

Severe forms of partial androgen insensitivity syndrome due to p.L830F novel mutation in androgen receptor gene in a Brazilian family
por: Petroli, Reginaldo J, et al.
Publicado: (2011)

SCREENING FOR MENTAL HEALTH PROBLEMS IN PRESCHOOLERS AT PRIMARY HEALTH CARE SETTINGS
por: dos Santos, Raquel Godinho Hokama, et al.
Publicado: (2017)

Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency
por: Veiga-Junior, Nélio Neves, et al.
Publicado: (2012)

A study of splicing mutations in disorders of sex development
por: de Calais, Flavia Leme, et al.
Publicado: (2017)

Long-Term Follow-Up of Patients with 46,XY Partial Gonadal Dysgenesis Reared as Males
por: Gabriel Ribeiro de Andrade, Juliana, et al.
Publicado: (2014)

Screening of Y chromosome microdeletions in 46,XY partial gonadal dysgenesis and in patients with a 45,X/46,XY karyotype or its variants
por: dos Santos, Ana Paula, et al.
Publicado: (2013)

A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins
por: Esquiaveto-Aun, Adriana Mangue, et al.
Publicado: (2015)

SUN-086 Pilot Study Using Aromatase Inhibitor in Puberty of Boys With Partial Androgen Insensitivity: Report of Three Cases
por: Maciel-Guerra, Andrea Trevas, et al.
Publicado: (2020)

NPHS2 mutations account for only 15 % of nephrotic syndrome cases
por: Guaragna, Mara Sanches, et al.
Publicado: (2015)

The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency
por: Fabbri, Helena Campos, et al.
Publicado: (2014)

Molecular Diagnosis of 5α-Reductase Type II Deficiency in Brazilian Siblings with 46,XY Disorder of Sex Development
por: de Calais, Flávia Leme, et al.
Publicado: (2011)

Androgens by immunoassay and mass spectrometry in children with 46,XY disorder of sex development
por: Oliveira, Letícia Ribeiro, et al.
Publicado: (2020)

DHX37 and NR5A1 Variants Identified in Patients with 46,XY Partial Gonadal Dysgenesis
por: de Oliveira, Felipe Rodrigues, et al.
Publicado: (2023)

Leydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion: a case-control study
por: Guaragna-Filho, Guilherme, et al.
Publicado: (2022)

Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study
por: Folquitto, Jefferson Cunha, et al.
Publicado: (2010)

Functional and Structural Consequences of Nine CYP21A2 Mutations Ranging from Very Mild to Severe Effects
por: de Paula Michelatto, Débora, et al.
Publicado: (2016)

NPHS2 Mutations: A Closer Look to Latin American Countries
por: Guaragna, Mara Sanches, et al.
Publicado: (2017)

Clinical and laboratory differences between chromosomal and undefined causes of non-obstructive azoospermia: A retrospective study
por: Riccetto, Luísa, et al.
Publicado: (2022)

Two cases of life‐threatening arrhythmia induced by risperidone: evaluation of risperidone and 9‐hydroxy‐risperidone concentrations
por: Ito, Asami, et al.
Publicado: (2017)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Severe granulocytopenia in a patient on long-term use of clozapine and with COVID-19
por: Pereira, Victoria de Carvalho, et al.
Publicado: (2021)

A de novo mutation in CYP21A2 gene in a case of in vitro fertilization
por: Silva-Grecco, Roseane Lopes da, et al.
Publicado: (2015)

Bariatric surgery as a treatment for refractory obesity in patients with schizophrenia. Weight-loss outcomes and safety in 36 months follow-up
por: Lorencetti, P., et al.
Publicado: (2022)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Galactorrhea Induced by Risperidone
por: Sakaguchi, Shota, et al.
Publicado: (2019)

Audit on prolactin monitoring for patients on oral risperidone, intramuscular risperidone, and intramuscular paliperidone
por: Bader, Mohamed
Publicado: (2021)

DELUSIONAL PARASITOSIS RESPONDING TO RISPERIDONE
por: Gowda, B.S.Narayana, et al.
Publicado: (2002)

Risperidone in the treatment of bipolar mania
por: Sajatovic, Martha, et al.
Publicado: (2006)

RISPERIDONE-INDUCED OCULOGYRIC CRISIS
por: Khalid, Abdul, et al.
Publicado: (2000)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

A Case of Priapism with Risperidone
por: Ginory, Almari, et al.
Publicado: (2014)

Development of Risperidone PLGA Microspheres
por: D'Souza, Susan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i9d24t04lmrst35cenl5p1fh22